RPTX - Repare gets FDA fast track status for ovarian cancer drug combo June, 04 2024 04:28 PM Repare Therapeutics Inc. 2024-06-04 16:28:44 ET More on Repare Therapeutics Repare Therapeutics appoints Steven Stein to its board of directors Seeking Alpha’s Quant Rating on Repare Therapeutics Historical earnings data for Repare Therapeutics Financial information for Repare Therapeutics For further details see: Repare gets FDA fast track status for ovarian cancer drug combo